Mereo BioPharma Group plc 10-K for FY2025
Mereo BioPharma Group plc (MREO)
10-K
2026-03-19
For: 2025-12-31
View Original
Added on
April 08, 2026
About this 10-K
Mereo BioPharma Group plc filed this 10-K on March 19, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $500K
- compared with $0 a year earlier
- Net loss
- $41.88M
- compared with a net loss of $43.25M a year earlier
- Diluted EPS
- -$0.05
- compared with -$0.06 a year earlier